After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

Last week, readers were most interested in a story about Pluslife's MiniDock MTB, the only test in WHO's new class designation for tuberculosis diagnostic tests.

Labcorp said that the loan, which was provided by Wells Fargo and PNC, will be used for general corporate purposes.

Intelligenome will contribute its testing platform to an NIH-funded program centered on cell-free DNA tuberculosis detection from respiratory and blood samples.

The companies will work together to develop new antibody-based technologies for pathology and other applications.

The firms, based in the UK and in France, are collaborating to develop an ELISA assay for a novel biomarker of severe sepsis known as oxidized pentraxin 3, or ox-PTX3.

NEW YORK – Anatomic pathology firm Sakura Finetek and imaging company Hamamatsu Photonics announced on Friday an alliance to standardize digital pathology slides and images. The companies intend to ...

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

The research team created a point-of-care assay that can detect bacterial STIs, including chlamydia and gonorrhea.

NEW YORK – Trinity Biotech announced on Thursday that it has entered into a collaboration agreement with the University at Buffalo in New York to commercialize proprietary novel biomarkers for Sjögren ...

The test allows for quantitative measurement of the protein neurofilament light chain – a marker of neuroaxonal injury – in plasma and serum.